← Back to Search

Behavioral Intervention

Parent Training for Early Social Communication Delays Related to Autism (SibWatch Trial)

N/A
Recruiting
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
No known hearing or vision loss
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately following the intervention period
Awards & highlights

SibWatch Trial Summary

This trial is testing a new intervention to improve social communication skills in toddlers who have siblings with autism. The goal is to see if the intervention is feasible, acceptable, and effective.

Who is the study for?
This trial is for toddlers who have a sibling with autism and are at high risk for communication challenges. They must not have hearing or vision loss, and their caregiver should speak English well enough to engage in the study's activities. Caregivers need to use English with the toddler at least half of the day. Toddlers already receiving early intervention services cannot participate.Check my eligibility
What is being tested?
The study tests an adaptive intervention called 'Improving Parents as Communication Teachers' aimed at enhancing social communication in toddlers at high risk due to having a sibling with autism. It will assess how feasible, acceptable, and effective this parent-mediated support strategy is.See study design
What are the potential side effects?
Since this trial involves educational and behavioral interventions rather than medical treatments, traditional physical side effects are not expected. However, participants may experience varying levels of engagement or stress related to participation.

SibWatch Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I do not have any known hearing or vision loss.

SibWatch Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately following the intervention period
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately following the intervention period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Child social communication
Parent implementation

SibWatch Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention firstExperimental Treatment1 Intervention
Participants will first be randomly assigned to a parent-mediated social communication intervention. At month 3 participants' social communication will be evaluated. Participants who present with delayed social communication skills will be randomly assigned to 2 additional treatment options: continue, or add video feedback. Participants who do not present with social communication delays will reduce intervention to a weekly phone call.
Group II: Developmental monitoring firstActive Control1 Intervention
Participants will first be assigned to receive monthly monitoring of social communication development. At month 3 participants' social communication will be evaluated. Participants who present with delayed social communication skills will be randomly assigned to 2 additional treatment options: continue, or add video feedback. Participants who do not present with social communication delays will continue to receive developmental monitoring.

Find a Location

Who is running the clinical trial?

University of Texas at AustinLead Sponsor
353 Previous Clinical Trials
81,200 Total Patients Enrolled

Media Library

Improving Parents as Communication Teachers (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05307094 — N/A
Autism Research Study Groups: Intervention first, Developmental monitoring first
Autism Clinical Trial 2023: Improving Parents as Communication Teachers Highlights & Side Effects. Trial Name: NCT05307094 — N/A
Improving Parents as Communication Teachers (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05307094 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has recruitment commenced for this trial?

"According to clinicaltrials.gov's current records, this medical trial is actively recruiting applicants. This study was initially advertised on January 15th 2022 and has since been updated as of November 1st 2022."

Answered by AI

Am I able to partake in this research project?

"This trial is looking for 44 infant and toddlers aged between 11-18 months who have a sibling with an autism diagnosis. Additionally, the caregiver must be fluent in English as all interventions and assessments are conducted in that language. Moreover, there should not be any known hearing or vision impairment and 50% of daily communication should occur in English."

Answered by AI

Is the enrollment criteria restricted to individuals aged 20 and over?

"The focus of this study is on infants aged between 1 year and 18 months."

Answered by AI

How many participants are taking part in this experiment?

"That is correct. Clinicaltrials.gov indicates that this experiment, which was originally uploaded on January 15th 2022, is currently accepting participants. The clinical trial seeks to enroll 44 individuals across a solitary medical centre."

Answered by AI

Who else is applying?

What state do they live in?
Texas
What site did they apply to?
The University of Texas at Austin
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Optimizing Intervention Options for Toddlers With Early Social Communication Delays
2022. "Optimizing Intervention Options for Toddlers With Early Social Communication Delays". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05307094.
All > Autism Austin
~2 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top